药明合联：Ambitious capacity expansion to continue-20260325

25 Mar 2026 CMB International Global Markets | Equity Research | Company Update WuXi XDC (2268 HK) WuXi XDC (2268 HK) - Ambitious capacity expansion to continue WuXi XDC reported 2025 financial results, delivering a robust 46.7% YoY increase in revenue with a significant YoY growth of 69.9% for adj. attributable net profit. The Company's 2025 revenue slightly beat our forecast by 0.6%, whereas its adj. net profit came in marginally below our estimate by 1.6%. As of the end of 2025, its backlog surged by 50. ...